In vitro PA studies. Bacterial plasmids encoding several far-red GFP-like FPs were kindly provided by Benjamin Glick (University of Chicago, USA) and Dmitry Chudakov and Konstantin Lukyanov (both from the Institute of Bioorganic Chemistry, Moscow, Russia).
Recombinant GFP-like FPs were expressed in LMG194 bacterial cells and purified using a Ni-NTA agarose (Qiagen). The purified FP solutions were diluted to equal concentrations of 32 µM. and imaged at 600 nm and 680 nm with ~90 mJ incident energy, using a 512 element ring transducer PACT system with top illumination from an OPO laser (Vibrant 335 I) [1] . The wavelengths were chosen to cover wavelengths near the peak excitation of each of FPs. The signal amplitude was compensated for laser power differences using a photodiode signal for normalization, and the signal from each FP was further normalized to blood absorption for comparison.
The depth analysis phantom consisted of approximately 20.00 mm long, 1.47 mm i.d.
tubing sections (Silastic Laboratory) filled with either iRFP or blood for comparison. The sections were then embedded in the chicken breast tissue and imaged using deep-PAM, with illumination provided by a Ti-Sapphire laser (LT-2211A) at 700 nm and approximately 100 mJ incident energy [2] . Deep-PAM was used for its reflection mode geometry, allowing for easier simulation of depth imaging. The illumination wavelength of 700 nm enabled delivery of greater laser energy with a similar protein absorption efficiency. Additional depths were simulated by stacking sections of chicken breast tissue on the sample surface. Twenty Bmode images were averaged at each depth. The noise equivalent concentration was calculated by dividing the known concentration of the absorber by the SNR of the sample, and provided an estimate of the expected minimum concentration detectable by the system for this sample. Stably EGFP-expressing and TagRFP657-expressing MTLn3 cells were described previously [3] . For PACT, two mice were imaged at the tumor region at two weeks and three weeks post inoculation using three wavelengths, 700 nm, 760 nm, and 796 nm. For spectral separation, the images were then processed using a linear least squares method for the three absorbers [4] . For clear separation from blood, the wavelengths were chosen such that absorption by iRFP is near the maximum at 700 nm, and essentially zero at the other wavelengths.
In vivo
Two and three weeks post injection, a 15 mm by 15 mm area was imaged using the deep-PAM system. Images were taken at the same near-IR wavelengths as the PACT experiment, with depth simulated by stacking approximately 4 mm of the chicken breast tissue over the sample. The same least square method was performed for spectral separation at both depths. To assess the iRFP concentration, we assumed the average total hemoglobin concentration to be similar through the depths imaged, and we normalized the calculated concentrations of iRFP to the average total hemoglobin concentration at each depth. Given the literature value for total hemoglobin concentration of 2.3 mM, the estimated maximum iRFP concentration would then be between 21 to 22 µM.
All animal experiments were performed in an AAALAC approved facility, using protocols approved by the Washington University in St. Louis Animal Use Committee. mKate2 [5] 588 633 56,400 0.39 34,404 mNeptune [5] 600 650 59,000 0.20 47,200 eqFP670 [6] 605 670 70,000 0.06 65,800
E2-Crimson [6] 605 646 58,500 0.12 51,480
TagRFP657 [5] 611 657 34,000 0.10 30,600 iRFP [7] 690 713 105,000 0.06 98,700
